Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Shares Issued (2023 - 2025)

Neuraxis (NRXS) has disclosed Shares Issued for 3 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, up 26018.89% year-over-year, with the annual reading at $7.7 million for FY2025, 29420.33% up from the prior year.
  • Shares Issued hit $2.7 million in Q4 2025 for Neuraxis, down from $4.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.0 million in Q3 2025 to a low of -$617185.0 in Q4 2023.
  • Historically, Shares Issued has averaged $892421.3 across 3 years, with a median of $112493.0 in 2025.
  • Biggest YoY gain for Shares Issued was 100.02% in 2025; the steepest drop was 43.82% in 2025.
  • Year by year, Shares Issued stood at -$617185.0 in 2023, then surged by 71.8% to -$174070.0 in 2024, then skyrocketed by 1667.43% to $2.7 million in 2025.
  • Business Quant data shows Shares Issued for NRXS at $2.7 million in Q4 2025, $4.0 million in Q3 2025, and $29.0 in Q2 2025.